Overview Belatacept in Liver Transplant Recipients Status: Terminated Trial end date: 2011-06-01 Target enrollment: Participant gender: Summary The purpose of this clinical research study is to evaluate the effects of belatacept, relative to tacrolimus, on the incidence of rejection, graft loss and death in subjects receiving a liver transplant Phase: Phase 2 Details Lead Sponsor: Bristol-Myers SquibbTreatments: AbataceptBasiliximabMycophenolate mofetilMycophenolic AcidTacrolimus